2024
Clinician and Practice Characteristics Associated With Support of Office-Based Methadone: Findings From a National Survey.
Sung M, Black A, Blevins D, Henry B, Cates-Wessel K, Dawes M, Hagle H, Joudrey P, Molfenter T, Levin F, Fiellin D, Edelman E. Clinician and Practice Characteristics Associated With Support of Office-Based Methadone: Findings From a National Survey. Journal Of Addiction Medicine 2024 PMID: 39475119, DOI: 10.1097/adm.0000000000001388.Peer-Reviewed Original ResearchOpioid use disorderCharacteristics associated with supportTreatment of opioid use disorderMultivariate logistic regression modelOffice-based settingSequential multivariable logistic regression modelsOpioid treatment programsLogistic regression modelsAcademic medical centerUse disorderInclusion criteriaMethadoneMedical CenterPatientsOffice-basedCOVID-19 surveyClinician supportPractice characteristicsLongitudinal treatmentImplementation barriersPolicy changesMOUDOutcome variablesImprove accessNational survey
2022
The impact of benzodiazepine exposure on treatment retention in an open-access methadone program: A retrospective cohort study
Morford K, Tetrault J, Zhou B, Li F, Gleeson B, Edelman E, Stein M, Barry D, Madden L. The impact of benzodiazepine exposure on treatment retention in an open-access methadone program: A retrospective cohort study. Drug And Alcohol Dependence 2022, 241: 109707. PMID: 36423462, PMCID: PMC9777057, DOI: 10.1016/j.drugalcdep.2022.109707.Peer-Reviewed Original ResearchConceptsBenzodiazepine exposureRetrospective cohort studyKaplan-Meier analysisTreatment retentionCohort studyCox regressionTreatment durationMedian treatment durationMultivariable Cox regressionCohort of patientsOpioid treatment programsOpioid use disorderLog-rank testSame-day accessDrug Administration recommendationsTreatment discontinuationUrine toxicologyMeier analysisMethadone programsUse disordersPatientsAdministration recommendationsTreatment entryTreatment programTreatment barriers